25912140,25901786,25206352,23621690,23202519,23043100,22728817,22553496,22509177,22379088,22347227,21741003,20571604,20538015,20463065,20174454,20096141,20012521,19837465,19826902,19694548,19669862,19487726,19149995,19149577,19038776,19008196,1897692 - Search Results

Year	Number of Results
2003	2
2004	8
2005	2
2006	3
2007	1
2008	10
2009	11
2010	5
2011	1
2012	6
2013	1
2014	1
2015	2
2024	0

1

Both Rbx1 and Rbx2 exhibit a functional role in the HIV-1 Vif-Cullin5 E3 ligase complex in vitro.

Wang X, Wang X, Wang W, Zhang J, Wang J, Wang C, Lv M, Zuo T, Liu D, Zhang H, Wu J, Yu B, Kong W, Wu H, Yu X. Wang X, et al. Biochem Biophys Res Commun. 2015 Jun 12;461(4):624-9. doi: 10.1016/j.bbrc.2015.04.077. Epub 2015 Apr 23. Biochem Biophys Res Commun. 2015. PMID: 25912140

2

ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction.

Miyakawa K, Matsunaga S, Kanou K, Matsuzawa A, Morishita R, Kudoh A, Shindo K, Yokoyama M, Sato H, Kimura H, Tamura T, Yamamoto N, Ichijo H, Takaori-Kondo A, Ryo A. Miyakawa K, et al. Nat Commun. 2015 Apr 22;6:6945. doi: 10.1038/ncomms7945. Nat Commun. 2015. PMID: 25901786 Free PMC article.

3

Suppression of APOBEC3-mediated restriction of HIV-1 by Vif.

Feng Y, Baig TT, Love RP, Chelico L. Feng Y, et al. Front Microbiol. 2014 Aug 26;5:450. doi: 10.3389/fmicb.2014.00450. eCollection 2014. Front Microbiol. 2014. PMID: 25206352 Free PMC article. Review.

4

Viral infectivity factor: a novel therapeutic strategy to block HIV-1 replication.

Yang G, Xiong X. Yang G, et al. Mini Rev Med Chem. 2013 Jun;13(7):1047-55. doi: 10.2174/1389557511313070008. Mini Rev Med Chem. 2013. PMID: 23621690 Review.

5

Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein.

Münk C, Jensen BE, Zielonka J, Häussinger D, Kamp C. Münk C, et al. Viruses. 2012 Nov 14;4(11):3132-61. doi: 10.3390/v4113132. Viruses. 2012. PMID: 23202519 Free PMC article. Review.

6

The restriction factors of human immunodeficiency virus.

Harris RS, Hultquist JF, Evans DT. Harris RS, et al. J Biol Chem. 2012 Nov 30;287(49):40875-83. doi: 10.1074/jbc.R112.416925. Epub 2012 Oct 5. J Biol Chem. 2012. PMID: 23043100 Free PMC article. Review.

7

The role of Vif oligomerization and RNA chaperone activity in HIV-1 replication.

Batisse J, Guerrero S, Bernacchi S, Sleiman D, Gabus C, Darlix JL, Marquet R, Tisné C, Paillart JC. Batisse J, et al. Virus Res. 2012 Nov;169(2):361-76. doi: 10.1016/j.virusres.2012.06.018. Epub 2012 Jun 21. Virus Res. 2012. PMID: 22728817 Review.

8

HIV Restriction Factors and Mechanisms of Evasion.

Malim MH, Bieniasz PD. Malim MH, et al. Cold Spring Harb Perspect Med. 2012 May;2(5):a006940. doi: 10.1101/cshperspect.a006940. Cold Spring Harb Perspect Med. 2012. PMID: 22553496 Free PMC article. Review.

9

Vpu and BST2: Still Not There Yet?

Sato K, Gee P, Koyanagi Y. Sato K, et al. Front Microbiol. 2012 Apr 9;3:131. doi: 10.3389/fmicb.2012.00131. eCollection 2012. Front Microbiol. 2012. PMID: 22509177 Free PMC article.

10

Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.

Zuo T, Liu D, Lv W, Wang X, Wang J, Lv M, Huang W, Wu J, Zhang H, Jin H, Zhang L, Kong W, Yu X. Zuo T, et al. J Virol. 2012 May;86(10):5497-507. doi: 10.1128/JVI.06957-11. Epub 2012 Feb 29. J Virol. 2012. PMID: 22379088 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

52 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year